Noninfectious ocular complications refer to a range of eye-related issues that are not caused by infectious agents but often result from underlying medical conditions, trauma, or systemic diseases. These complications can affect various structures within the eye, leading to visual impairment and discomfort. Conditions such as diabetic retinopathy, glaucoma, and macular degeneration fall under the category of noninfectious ocular complications. These often involve damage to the blood vessels, increased intraocular pressure, or degeneration of the macula, respectively. Other examples include dry eye syndrome, uveitis, and retinal detachment, which can arise due to autoimmune disorders, inflammation, or mechanical factors. Ocular complications can also be associated with systemic conditions like diabetes, hypertension, and autoimmune diseases. Treatment approaches for noninfectious ocular complications may include medications, surgical interventions, or lifestyle modifications. Regular eye examinations are crucial for early detection and management of these conditions, helping preserve vision and overall eye health. Ongoing research aims to develop innovative therapies and improve our understanding of the mechanisms underlying noninfectious ocular complications.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy